In our current study, Black participants had higher mean levels of plasma Aβ42/40 than white participants regardless of amyloid status, sex, APOE ε4 carrier status, years of education, BMI, hypertension, or diabetes status. The gene discussed is APOE; the disease is hypertensive disorder.